Abstract:The purpose of this study was to evaluate the clinical application of endosseous implants for management of grafted alveolar cleft. Four patients (1 male and 3 female; mean age 26.6 years; age ranging from 21.5 to 30.4 years at first implant surgery) with unilateral cleft lip and palate were evaluated. All patients received autogenous particulate cancellous bone and marrow graft (PCBM) to close the alveolar cleft. After bone bridge formation, implant treatment was performed. All patients with insufficient alveolar bone height, chin or ramus of mandible bone, onlay grafting was performed 4 months before implant installment. A total of 5 implants were placed in the grafted alveoli. The length of implants ranged from 10.0 to 13.0 mm. The follow-up period ranged from 2.2 to 4.1 years after implant placement. The clinical result was acceptable in all patients. The survival rate of implants was 100%. Implant treatment for grafted alveolar cleft was studied and the outcome of treatment was acceptable.
Introduction
Dental rehabilitation of patients with alveolar cleft is the most challenging. Secondary bone grafting in alveolar clefts is a wellestablished procedure performed to close the oronasal fistula, allowing the teeth to erupt in the cleft lesion, provide bony support to the teeth adjacent to the cleft, stabilize the premaxillary segment of bilateral cases and create support for the alar base.
After bone grafting in the alveolar cleft, conventional prostheses such as removable partial endosseous dentures or dental bridges are used for dental reconstruction in such cases. Recently, some researchers reported the efficacy of dental implant after the repair of alveolar clefts with secondary bone grafting [1] [2] [3] [4] . However, few reports have examined the efficacy of dental implants in the grafted alveolar cleft. The aim of the present study is to examine the clinical efficacy of dental implants for grafted alveolar cleft.
Patients and methods

Patients
Four patients (1 male and 3 female) with alveolar cleft received dental implant treatment at the Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University
Medical and Dental Hospital. The distribution of patients is listed in Table. 1. All of the patients had unilateral cleft lip and palate.
The mean age at first implant surgery was 26.6 ± 3.9 years (range 21.5 to 30.4). Preoperative systemic examination revealed no significant health problems in any of the patients.
Methods (1) Bone grafting
All patients had received autogenous particulate cancellous and bone marrow (PCBM) graft from the ilium between 16.6 and 27.9 years of age (mean age, 22.1 ± 5.2).
(2) Evaluation of grafted bone
Preoperative evaluation of the bone bridges was performed with computed tomography (CT) and periapical radiographs.
Interdental alveolar bone height was evaluated as was previously reported by Takahashi et al 5) . Fig.1 
(3) Implant procedure
Three of the patients received autogenous bone from the mandibular chin bone onlay grafting (CBOG) to achieve sufficient height of alveolar bone 4 months before implant installment. A total of 5 Branemark System implants (Nobel Biocare, Japan, Tokyo) were placed based on the bone volume of the treated bone (Table 2 ). Six months after implant placement, appropriate abutments (Nobel Biocare, Japan, Tokyo) were connected.
Subsequently, a freestanding superstructure was used in all patients. Fig Table 1 The follow-up period after implant surgery ranged from 2.2 to 4.1 years (mean period 3.2 years). The clinical outcome was good in all cases and the patients were satisfied. All implants survived during the period of this short-term observation (5/5).
Discussion
In the present study, we investigated the clinical application of dental reconstruction with endosseous implants in patients with grafted alveolar clefts. Although many reports have demonstrated excellent results with dental implants histologically, radiographically and clinically [6] [7] [8] , few studies have examined the results of implant treatment in cleft lip and palate patients.
The use of commercial pure titanium implanted into maxilla and mandible facilitates direct bone apposition to the implant surface creating a unique bone-implant interface, which is termed osseointegration [9] [10] . The ability of titanium to achieve firm anchorage in bone without an intervening soft tissue layer is required for implant stability and longevity. Previous implant materials failed to match this quality 6) . It is the intimate relationship between host bone and the titanium implant surface that is responsible for the implant success rate. On the other hand, the alveolar ridge of cleft patients is usually reconstructed with PCBM.
The surface of implants installed in grafted alveolar cleft contacts the bony bridge in the cleft formed from grafted bone, which may sometimes include chin bone onlay or ramus bone additionally grafted to recover the insufficient height.
In this study, all patients had received PCBM graft from ilium to close the alveolar cleft prior to implant treatment. But 3 of the 4 patients required additional bone grafting to increase the alveolar height. We used mandibular chin bone to augment the alveolar height of the bony bridge of the alveolar cleft. This intraoral bone harvesting technique has been shown to be very acceptable for the treatment of patients with alveolar ridge atrophy resulting from trauma, tumor resection and periodontal disease. Raghoeverr et al. 11) reported a high success rate of 92% for dental implants with chin bone grafting. Jensen et al. 12) also reported a success rate of 95% for dental implants with autogenous bone graft harvested from the mandibular ramus. However, the efficacy of dental 88 with iliac PCBM has not been well investigated. The most difficult part of dental implant treatment in cleft lip and palate patients who have received multiple operations for cleft repair is the soft tissue management after chin bone onlay grafting. This is because the soft tissue has become too fibrous making difficult to close the bone augmented alveolaris graft. Therefore, dehiscence occurs easily after CBOG or ramus bone onlay grafting (RBOG).
Takahashi et al. 5) also described exposure of CBOG 2 weeks after surgery and failure of implant treatment. We also observed exposure of the grafted bone and resorption of the CBOG in case 2. These failures could be due to the simultaneous implant placement with bone grafting. The soft tissue was not adequate to cover the implant head and grafted onlay bone. The other 2 cases underwent implant surgery 4 months after CBOG and showed good prognosis in the observation period. We do not recommend the simultaneous implant placement with bone grafting.
The installed implants showed acceptable osseointegration without bone resorption after connecting the superstructure except case 2. Clinically, there were no problems in the other teeth and alveolar process. It was reported by Takahashi et al. 5) that within 19 cleft lip and palate (CLP) patients, half of them required CBOG to increase the alveolar bone height for placement of dental implants of adequate length. In our study also, 3 of the 4 patients required CBOG to increase alveolar height. On the other hand, Buser et al. 13) reported the efficacy of guided bone regeneration technique with a resorbable or non-resorbable membrane for atrophied alveolar ridge. Zaffe et al. 14) suggested callus distraction to increase bone height without bone grafting. We believe that the combination of these options with autogenous bone grafting might bring more satisfactory results in future.
We evaluated the clinical outcome of endosseous implants installed in the alveolar cleft repaired with autogenous PCBM graft. Our results suggest the efficacy of dental treatment in patients who underwent treatment of CLP repair with PCBM. Moreover, this treatment permits an acceptable esthetic outcome without the necessity of removable denture or bridge. 
